BlackRock’s Akoya BioSciences AKYA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $649K | Sell |
499,510
-1,112,492
| -69% | -$1.45M | ﹤0.01% | 4314 |
|
|
2025
Q1 | $2.24M | Sell |
1,612,002
-25,328
| -2% | -$35.2K | ﹤0.01% | 3915 |
|
|
2024
Q4 | $3.75M | Buy |
1,637,330
+57,166
| +4% | +$131K | ﹤0.01% | 3791 |
|
|
2024
Q3 | $4.3M | Buy |
1,580,164
+78,277
| +5% | +$213K | ﹤0.01% | 3708 |
|
|
2024
Q2 | $3.51M | Buy |
1,501,887
+154,348
| +11% | +$361K | ﹤0.01% | 3760 |
|
|
2024
Q1 | $6.32M | Sell |
1,347,539
-24,693
| -2% | -$116K | ﹤0.01% | 3522 |
|
|
2023
Q4 | $6.7M | Sell |
1,372,232
-72,770
| -5% | -$355K | ﹤0.01% | 3505 |
|
|
2023
Q3 | $6.72M | Buy |
1,445,002
+255,152
| +21% | +$1.19M | ﹤0.01% | 3484 |
|
|
2023
Q2 | $8.79M | Buy |
1,189,850
+193,305
| +19% | +$1.43M | ﹤0.01% | 3405 |
|
|
2023
Q1 | $8.15M | Sell |
996,545
-21,238
| -2% | -$174K | ﹤0.01% | 3353 |
|
|
2022
Q4 | $9.74M | Buy |
1,017,783
+43,004
| +4% | +$412K | ﹤0.01% | 3344 |
|
|
2022
Q3 | $11.5M | Buy |
974,779
+177,176
| +22% | +$2.08M | ﹤0.01% | 3293 |
|
|
2022
Q2 | $10.2M | Buy |
797,603
+20,602
| +3% | +$265K | ﹤0.01% | 3423 |
|
|
2022
Q1 | $8.54M | Buy |
777,001
+10,737
| +1% | +$118K | ﹤0.01% | 3584 |
|
|
2021
Q4 | $11.7M | Buy |
766,264
+355,867
| +87% | +$5.45M | ﹤0.01% | 3518 |
|
|
2021
Q3 | $5.73M | Sell |
410,397
-31,388
| -7% | -$438K | ﹤0.01% | 3848 |
|
|
2021
Q2 | $8.54M | Buy |
+441,785
| New | +$8.54M | ﹤0.01% | 3635 |
|